Candel Therapeutics (CADL) Prepaid Assets (2020 - 2025)
Candel Therapeutics (CADL) reported Prepaid Assets of $1.7 million for Q4 2025, up 44.17% on a YoY basis from $1.2 million in Q4 2024, and down 47.71% sequentially from $3.2 million in Q3 2025.
Candel Therapeutics (CADL) Prepaid Assets (2020 - 2025) Analysis & Trends
Candel Therapeutics (CADL) has 6 years of Prepaid Assets data on file, last reported at $1.7 million in Q4 2025.
- For the quarter ending Q4 2025, Prepaid Assets rose 44.17% year-over-year to $1.7 million; the trailing twelve-month figure through Dec 2025 stood at $1.7 million (up 44.17% YoY), and the FY2025 full-year result was $1.7 million, up 44.17% from the prior year.
- Prepaid Assets fell to $1.7 million in Q4 2025, from $3.2 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $3.2 million in Q3 2025 to a low of $110000.0 in Q2 2021.
- A 5-year average of $1.7 million and a median of $1.5 million in 2024 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets soared 2376.34% in 2021 and slumped 45.62% in 2024, its largest moves.
- Tracing CADL's Prepaid Assets over 5 years: stood at $2.3 million in 2021, then retreated by 18.06% to $1.9 million in 2022, then decreased by 26.66% to $1.4 million in 2023, then retreated by 16.91% to $1.2 million in 2024, then surged by 44.17% to $1.7 million in 2025.
- Business Quant data shows CADL's Prepaid Assets at $1.7 million in Q4 2025, $3.2 million in Q3 2025, and $2.9 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Candel Therapeutics | 542.51 Mn | 542.51 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.66 Mn |
| Sep 30, 2025 | 3.17 Mn |
| Jun 30, 2025 | 2.92 Mn |
| Mar 31, 2025 | 983,000.00 |
| Dec 31, 2024 | 1.15 Mn |
| Sep 30, 2024 | 1.53 Mn |
| Jun 30, 2024 | 1.28 Mn |
| Mar 31, 2024 | 1.42 Mn |
| Dec 31, 2023 | 1.38 Mn |
| Sep 30, 2023 | 2.12 Mn |
| Jun 30, 2023 | 1.47 Mn |
| Mar 31, 2023 | 2.62 Mn |
| Dec 31, 2022 | 1.89 Mn |
| Sep 30, 2022 | 1.89 Mn |
| Jun 30, 2022 | 544,000.00 |
| Mar 31, 2022 | 1.33 Mn |
| Dec 31, 2021 | 2.30 Mn |
| Sep 30, 2021 | 2.57 Mn |
| Jun 30, 2021 | 110,000.00 |
| Dec 31, 2020 | 93,000.00 |